Nautilus Biotechology Up on CNBC Report About Amazon Investment

 Nautilus Biotechnology Inc. shares were recently up 13% to $8.46 after CNBC reported that Amazon.com Inc. had invested in the company.

Amazon had previously disclosed the investment in a Form 13F filing.

Nautilus was briefly paused due to volatility several times Thursday. The life sciences company is focused on technology "for quantifying and unlocking the complexity of the proteome."

https://www.marketscreener.com/quote/stock/NAUTILUS-BIOTECHNOLOGY-I-123640055/news/Nautilus-Biotechology-Up-13-on-CNBC-Report-About-Amazon-Investment-36084596/